Japan’s Special Approval for Emergency System During the COVID‐19 Pandemic-Reference-Cited by-同舟云学术

Japan’s Special Approval for Emergency System During the COVID‐19 Pandemic

Published:2021-06-18 Issue:3 Volume:111 Page:551-558
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Maeda Hideki¹

Affiliation:

1. Department of Regulatory Science Faculty of Pharmacy Meiji Pharmaceutical University Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2310

Reference20 articles.

1. Remdesivir: First Approval

2. Pharmaceuticals and Medical Devices Agency (PMDA).Special approval for emergency on the first COVID‐19 vaccine in Japan. Accessed May 10 2021.

3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

4. Ministry of Health Labour and Welfare.Information on the Special Approval of GSK's Vaccine "Alepanrix (H1N1) Intramuscular Injection"[in Japanese] . Accessed May 10 2021.

5. Ministry of Health Labour and Welfare.Information on the special approval of Novartis' vaccine "Emulsion cell culture influenza A HA vaccine H1N1 [Novartis] for intramuscular injection"[in Japanese] . AccessedMay 10 2021.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and effectiveness of remdesivir in a postmarketing surveillance study in Japan;Respiratory Investigation;2024-03

2. A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future;Expert Review of Anti-infective Therapy;2022-11-15

3. Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform;Osong Public Health and Research Perspectives;2022-02-28

4. The Pandemic as a Catalyst for Disruptive Innovation in Clinical Pharmacology;Clinical Pharmacology & Therapeutics;2022-02-08

5. Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis;Expert Review of Vaccines;2022-01-24